Oteseconazole (VT-1161) 150mg capsule

DRUG2 trials

Sponsors

Mycovia Pharmaceuticals Inc., Beijing Tsinghua Chang Gung Hospital

Conditions

Recurrent Vulvovaginal CandidiasisVulvovaginal Candidiasis

Phase 3

Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections

CompletedNCT03840616

Mycovia Pharmaceuticals Inc.Recurrent Vulvovaginal Candidiasis

Start: 2019-03-13End: 2020-12-02Updated: 2022-02-04

Unknown Phase

Oteseconazole in the Treatment of Adults With Vulvovaginal Candidiasis（VVC）

Not yet recruitingNCT07044947

Beijing Tsinghua Chang Gung HospitalVulvovaginal Candidiasis

Start: 2025-08-10End: 2030-08-10Target: 3000Updated: 2025-07-01